ATE408689T1 - Protein spezifisch für die pankreatischen beta- zellen der langerhans-inseln, und seine verwendungen - Google Patents

Protein spezifisch für die pankreatischen beta- zellen der langerhans-inseln, und seine verwendungen

Info

Publication number
ATE408689T1
ATE408689T1 AT03786019T AT03786019T ATE408689T1 AT E408689 T1 ATE408689 T1 AT E408689T1 AT 03786019 T AT03786019 T AT 03786019T AT 03786019 T AT03786019 T AT 03786019T AT E408689 T1 ATE408689 T1 AT E408689T1
Authority
AT
Austria
Prior art keywords
cells
sequence
protein
nucleic acid
iia
Prior art date
Application number
AT03786019T
Other languages
English (en)
Inventor
Michel Seve
Alain Favier
Original Assignee
Commissariat Energie Atomique
Univ Grenoble 1
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat Energie Atomique, Univ Grenoble 1 filed Critical Commissariat Energie Atomique
Application granted granted Critical
Publication of ATE408689T1 publication Critical patent/ATE408689T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
AT03786019T 2002-11-18 2003-11-18 Protein spezifisch für die pankreatischen beta- zellen der langerhans-inseln, und seine verwendungen ATE408689T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0214374A FR2847263B1 (fr) 2002-11-18 2002-11-18 Polynucleotide specifique de la cellule pancreatique beta des ilots de langerhans

Publications (1)

Publication Number Publication Date
ATE408689T1 true ATE408689T1 (de) 2008-10-15

Family

ID=32187667

Family Applications (2)

Application Number Title Priority Date Filing Date
AT08002520T ATE494376T1 (de) 2002-11-18 2003-11-18 Spezielles protein der pankreatischen beta-zellen der langerhans-inseln und seine anwendungen
AT03786019T ATE408689T1 (de) 2002-11-18 2003-11-18 Protein spezifisch für die pankreatischen beta- zellen der langerhans-inseln, und seine verwendungen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT08002520T ATE494376T1 (de) 2002-11-18 2003-11-18 Spezielles protein der pankreatischen beta-zellen der langerhans-inseln und seine anwendungen

Country Status (12)

Country Link
US (2) US7851164B2 (de)
EP (3) EP1563071B1 (de)
JP (2) JP4498144B2 (de)
CN (2) CN102250242A (de)
AT (2) ATE494376T1 (de)
AU (1) AU2003295025B2 (de)
CA (1) CA2506331C (de)
DE (2) DE60323664D1 (de)
DK (2) DK1925667T3 (de)
ES (3) ES2454592T3 (de)
FR (1) FR2847263B1 (de)
WO (1) WO2004046355A2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008065544A2 (en) * 2006-09-11 2008-06-05 Mcgill University Genetic predictors of risk for type 2 diabetes mellitus
ES2533566T3 (es) * 2006-12-29 2015-04-13 The Regents Of The University Of Colorado, A Body Corporate Diana diagnóstica y terapéutica para enfermedades autoinmunitarias y sus usos
WO2008096009A2 (en) * 2007-02-09 2008-08-14 Mellitech Polymorphism in the slc30a8 gene
EP2247717B1 (de) 2008-02-14 2016-04-13 Université Libre de Bruxelles Plasmamembran-biomarker mit bevorzugter expression in beta-zellen des pankreas und eignung bei der bildgebung von oder dem abzielen auf beta-zellen
EP2334696A1 (de) * 2008-09-30 2011-06-22 Novo Nordisk A/S G6pc2-kodierte betazelloberflächenmarker
WO2010054096A1 (en) * 2008-11-07 2010-05-14 The Cleveland Clinic Foundation Method for detecting and purifying pancreatic beta cells
JP6128848B2 (ja) * 2009-08-05 2017-05-17 クルナ・インコーポレーテッド インスリン遺伝子（ｉｎｓ）に対する天然アンチセンス転写物の抑制によるインスリン遺伝子（ｉｎｓ）関連疾患の治療
EP2537859A1 (de) 2011-06-23 2012-12-26 Université de Mons Moleküle zur spezifischen Bindung pankreatischer Betazellen-Biomarker
IN2014DN09410A (de) 2012-04-13 2015-07-17 Diabetomics Llc
CN104098675A (zh) * 2013-04-03 2014-10-15 苏州偲聚生物材料有限公司 多肽、包含该多肽的检测器件和检测试剂盒
CN104098673A (zh) * 2013-04-03 2014-10-15 苏州偲聚生物材料有限公司 多肽、包含该多肽的检测器件和检测试剂盒
WO2015144861A1 (en) 2014-03-26 2015-10-01 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Flattop (fltp) is a novel biomarker for beta cell maturation
GB201520568D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd Peptides
GB201520603D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520550D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
US11016085B2 (en) 2016-04-25 2021-05-25 The Johns Hopkins University ZNT8 assays for drug development and pharmaceutical compositions
CN106226526A (zh) * 2016-06-30 2016-12-14 深圳市亚辉龙生物科技股份有限公司 一种锌转运蛋白8抗体化学发光免疫检测试剂盒及其制备方法
EP3652540A4 (de) 2017-07-12 2021-04-07 The Johns Hopkins University Auf proteoliposom basierendes znt-8-selbstantigen zur diagnose von typ-1-diabetes
WO2020037174A1 (en) * 2018-08-16 2020-02-20 The Johns Hopkins University Antibodies to human znt8
CN109734793B (zh) * 2019-03-14 2022-12-02 深圳市药品检验研究院（深圳市医疗器械检测中心） 一种ZnT8重组蛋白及其制备方法和应用
CA3150758A1 (en) * 2019-08-13 2021-02-18 Amgen Inc. Rnai constructs for inhibiting slc30a8 expression and methods of use thereof
US12366570B2 (en) 2019-10-01 2025-07-22 The Johns Hopkins University Cell-based ZNT8 assay
US20250129153A1 (en) 2021-08-20 2025-04-24 The Johns Hopkins University Cell-surface antibody to a specific biomarker of pancreatic beta-cells

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
NL9001083A (nl) 1990-05-04 1991-12-02 Rijksuniversiteit Beta-cel antigeen.
ZA97476B (en) * 1996-01-22 1998-07-21 Res Dev Foundation Novel methods for the characterization of compounds which stimulate STF-1 expression in pancreatic islet cells.
WO2001042789A1 (en) * 1999-12-13 2001-06-14 The Scripps Research Institute MARKERS FOR IDENTIFICATION AND ISOLATION OF PANCREATIC ISLET α AND β CELL PROGENITORS
WO2001094409A2 (en) * 2000-06-07 2001-12-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of pancreatic cancer
CA2421576A1 (en) * 2000-09-15 2002-03-28 Curagen Corporation Human polynucleotides and polypeptides encoded thereby
AU2002246708A1 (en) * 2000-12-15 2002-08-12 Agensys, Inc. Nucleic acid and encoded zinc transporter protein entitled 108p5h8 useful in treatment and detection of cancer

Also Published As

Publication number Publication date
WO2004046355A2 (fr) 2004-06-03
EP2239272A2 (de) 2010-10-13
DK1925667T3 (da) 2011-04-26
EP1925667A1 (de) 2008-05-28
US20060246442A1 (en) 2006-11-02
DK1563071T3 (da) 2009-02-02
EP2239272B1 (de) 2014-01-01
US9568482B2 (en) 2017-02-14
FR2847263B1 (fr) 2006-01-13
ES2361639T3 (es) 2011-06-20
EP1563071B1 (de) 2008-09-17
FR2847263A1 (fr) 2004-05-21
WO2004046355A3 (fr) 2004-09-30
AU2003295025A1 (en) 2004-06-15
CA2506331C (fr) 2015-02-17
ES2314268T3 (es) 2009-03-16
JP2010150262A (ja) 2010-07-08
EP1925667B1 (de) 2011-01-05
ES2454592T3 (es) 2014-04-11
AU2003295025B2 (en) 2008-09-18
EP2239272A3 (de) 2010-12-08
JP5202550B2 (ja) 2013-06-05
DE60323664D1 (de) 2008-10-30
JP4498144B2 (ja) 2010-07-07
CN1738900A (zh) 2006-02-22
DE60335676D1 (de) 2011-02-17
CN1738900B (zh) 2011-07-06
US7851164B2 (en) 2010-12-14
ATE494376T1 (de) 2011-01-15
EP1563071A2 (de) 2005-08-17
US20110027807A1 (en) 2011-02-03
JP2006506084A (ja) 2006-02-23
CN102250242A (zh) 2011-11-23
CA2506331A1 (fr) 2004-06-03

Similar Documents

Publication Publication Date Title
ATE494376T1 (de) Spezielles protein der pankreatischen beta-zellen der langerhans-inseln und seine anwendungen
JP2006506084A5 (de)
CN109266680B (zh) 一种应用Cas9技术制备CKO/KI动物模型的方法
US20250122573A1 (en) Method to predict the pattern of locomotion in horses
IL180201A0 (en) Diagnostic and screening methods and kits associated with proteolytic activity
RU2009135270A (ru) Способы выявления воспалительного заболевания кишечника
EP2088207A1 (de) Biomarker und Verfahren zur Identifizierung von Mitteln, die bei der Behandlung affektiver Psychosen von Nutzen sind
CN101568646A (zh) 基因扩增用引物对、含有其的基因扩增用试剂及其用途
CA2915540A1 (en) A method and quality control molecular based mouse embryo assay for use with in vitro fertilization technology
EP2502994A1 (de) Primer-set zur verstärkung des mthfr-gens, reagens zur verstärkung des mthfr-gens damit und anwendung davon
KR102124652B1 (ko) 개의 불안장애 조기 예측 또는 진단용 조성물
CN101619350A (zh) 用于恶性肿瘤个体化用药相关基因突变检测的基因芯片及其应用
Sawai et al. Analysis of mRNA transcripts for insulin-like growth factor receptors and binding proteins in bovine embryos derived from somatic cell nuclear transfer
ZA200606354B (en) Method of identifying genes which promote hybrid vigour and hybrid debility and uses thereof
US10704098B2 (en) Diagnosis and treatment of genetic alterations associated with eosinophilic esophagitis
KR102144673B1 (ko) 참외의 품종 구별 및 f1 종자 순도검정을 위한 snp 기반 kasp용 프라이머 세트 및 이의 용도
CN106434947B (zh) Wnt5a基因作为猪产仔数性状相关检测的分子标记
KR101821552B1 (ko) 돼지의 유두수 예측용 ｓｎｐ 마커 및 이를 이용한 다산 개체 예측방법
KR20170048206A (ko) XBP-1(X-box binding protein 1) 유전자를 이용한 소포체 스트레스 분석용 조성물
EP2586787A1 (de) DEP2 und dessen Verwendung bei schwerer Depression und anderen verwandten Leiden
JP7833917B2 (ja) 汗腺細胞および汗腺組織の老化を評価する方法、並びに、被験試料の汗腺細胞および汗腺組織に対する老化調整効果を評価する方法
CN104630362A (zh) 一种精子细胞转录调控相关基因的基因检测方法
JP4430063B2 (ja) Ｗｆｄｃ１の変異を検出する先天性眼疾患の検査方法
JPWO2018199136A1 (ja) Ａｂｌ１ ｔ３１５ｉ変異の発現レベルの測定方法
CN101109705A (zh) 一种检测酒精中毒和酒精成瘾易感性的试剂盒

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
REN Ceased due to non-payment of the annual fee